BLUTKOMPONENTENTRENNVORRICHTUNG

European patent · EP3406276 · In force

Register entry

Publication number
EP3406276
Application number
EP16886518
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 20, 2016
Published
Nov 28, 2018
Granted
Jul 27, 2022
Protection ends at the latest
Dec 19, 2036
Next annual fee due
Dec 31, 2026
IPC classes
A61M 1/02 (2006.01)
A61M 1/36 (2006.01)
B04B 5/04 (2006.01)
Priority
JP 2016009739 21.01.2016
PCT application
PCT/JP2016/087953 20.12.2016
PCT publication
WO2017/126279 27.07.2017
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jun 7, 2023

    Change

    Published in Swissreg on 07.06.2023

  5. Jan 4, 2023

    Change

    Published in Swissreg on 04.01.2023

  6. Jul 29, 2022

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach, 8027 Zürich

    Published in Swissreg on 29.07.2022

  7. Jul 27, 2022

    Granted

    Published in Swissreg on 27.07.2022

Parties

Holder

Transell Co., Ltd.

2F, FtF Building, 1-2, Nihonbashi Hakozaki-cho, Chuo-ku,, Tokyo 103-0015, JP

Agent

Isler & Pedrazzini AG

Postfach, 8027 Zürich

Inventor

HAMADA, Nariyuki

Hiroshima, 730-8652, JP

SADO, Katsuyuki

Gunma, 370-0021, JP

KANEDA, Kenta

Gunma, 370-0021, JP

NAKAMURA, Shuji

Kanagawa 236-0043, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.